Olga Vujovic1, Edward Yu2, Anil Cherian3, A Rashid Dar2, Larry Stitt4, Francisco Perera2. 1. Department of Radiation Oncology, London Regional Cancer Program, London, Ontario, Canada. Electronic address: olga.vujovic@lhsc.on.ca. 2. Department of Radiation Oncology, London Regional Cancer Program, London, Ontario, Canada. 3. Station Health Centre, Royal Air Force Lossiemouth, Moray, United Kingdom. 4. Department of Biometry, London Regional Cancer Program, London, Ontario, Canada.
Abstract
PURPOSE: A retrospective chart review was conducted to determine whether the time interval from breast-conserving surgery to breast irradiation (surgery-radiation therapy interval) in early stage node-negative breast cancer had any detrimental effects on recurrence rates. METHODS AND MATERIALS: There were 566 patients with T1 to T3, N0 breast cancer treated with breast-conserving surgery and breast irradiation and without adjuvant systemic treatment between 1985 and 1992. The surgery-to-radiation therapy intervals used for analysis were 0 to 8 weeks (201 patients), >8 to 12 weeks (233 patients), >12 to 16 weeks (91 patients), and >16 weeks (41 patients). Kaplan-Meier estimates of time to local recurrence, disease-free survival, distant disease-free survival, cause-specific survival, and overall survival rates were calculated. RESULTS: Median follow-up was 17.4 years. Patients in all 4 time intervals were similar in terms of characteristics and pathologic features. There were no statistically significant differences among the 4 time groups in local recurrence (P=.67) or disease-free survival (P=.82). The local recurrence rates at 5, 10, and 15 years were 4.9%, 11.5%, and 15.0%, respectively. The distant disease relapse rates at 5, 10, and 15 years were 10.6%, 15.4%, and 18.5%, respectively. The disease-free failure rates at 5, 10, and 15 years were 20%, 32.3%, and 39.8%, respectively. Cause-specific survival rates at 5, 10, and 15 years were 92%, 84.6%, and 79.8%, respectively. The overall survival rates at 5, 10, and 15 years were 89.3%, 79.2%, and 66.9%, respectively. CONCLUSIONS: Surgery-radiation therapy intervals up to 16 weeks from breast-conserving surgery are not associated with any increased risk of recurrence in early stage node-negative breast cancer. There is a steady local recurrence rate of 1% per year with adjuvant radiation alone.
PURPOSE: A retrospective chart review was conducted to determine whether the time interval from breast-conserving surgery to breast irradiation (surgery-radiation therapy interval) in early stage node-negative breast cancer had any detrimental effects on recurrence rates. METHODS AND MATERIALS: There were 566 patients with T1 to T3, N0 breast cancer treated with breast-conserving surgery and breast irradiation and without adjuvant systemic treatment between 1985 and 1992. The surgery-to-radiation therapy intervals used for analysis were 0 to 8 weeks (201 patients), >8 to 12 weeks (233 patients), >12 to 16 weeks (91 patients), and >16 weeks (41 patients). Kaplan-Meier estimates of time to local recurrence, disease-free survival, distant disease-free survival, cause-specific survival, and overall survival rates were calculated. RESULTS: Median follow-up was 17.4 years. Patients in all 4 time intervals were similar in terms of characteristics and pathologic features. There were no statistically significant differences among the 4 time groups in local recurrence (P=.67) or disease-free survival (P=.82). The local recurrence rates at 5, 10, and 15 years were 4.9%, 11.5%, and 15.0%, respectively. The distant disease relapse rates at 5, 10, and 15 years were 10.6%, 15.4%, and 18.5%, respectively. The disease-free failure rates at 5, 10, and 15 years were 20%, 32.3%, and 39.8%, respectively. Cause-specific survival rates at 5, 10, and 15 years were 92%, 84.6%, and 79.8%, respectively. The overall survival rates at 5, 10, and 15 years were 89.3%, 79.2%, and 66.9%, respectively. CONCLUSIONS: Surgery-radiation therapy intervals up to 16 weeks from breast-conserving surgery are not associated with any increased risk of recurrence in early stage node-negative breast cancer. There is a steady local recurrence rate of 1% per year with adjuvant radiation alone.
Authors: Rajiv Dave; Rachel O'Connell; Tim Rattay; Zoe Tolkien; Nicola Barnes; Joanna Skillman; Paula Williamson; Elizabeth Conroy; Matthew Gardiner; Adrian Harnett; Ciara O'Brien; Jane Blazeby; Shelley Potter; Chris Holcombe Journal: BMJ Open Date: 2016-10-07 Impact factor: 2.692
Authors: Marissa C van Maaren; Reini W Bretveld; Jan J Jobsen; Renske K Veenstra; Catharina Gm Groothuis-Oudshoorn; Hendrik Struikmans; John H Maduro; Luc Ja Strobbe; Philip Mp Poortmans; Sabine Siesling Journal: Br J Cancer Date: 2017-06-06 Impact factor: 7.640
Authors: Laura M Spring; Michelle C Specht; Rachel B Jimenez; Steven J Isakoff; Gary X Wang; Amy Ly; Jennifer A Shin; Aditya Bardia; Beverly Moy Journal: N Engl J Med Date: 2020-07-01 Impact factor: 91.245